Merck KGaA (XTER:MRK) Other Long-Term Liabilities : €1,224 Mil (As of Mar. 2025)

View and export this data going back to 1995. Start your Free Trial

What is Merck KGaA Other Long-Term Liabilities?

Merck KGaA's other long-term liabilities for the quarter that ended in Mar. 2025 was €1,224 Mil.

Merck KGaA's quarterly other long-term liabilities stayed the same from Sep. 2024 (€1,295 Mil) to Dec. 2024 (€1,295 Mil) but then declined from Dec. 2024 (€1,295 Mil) to Mar. 2025 (€1,224 Mil).

Merck KGaA's annual other long-term liabilities declined from Dec. 2022 (€1,747 Mil) to Dec. 2023 (€1,570 Mil) and declined from Dec. 2023 (€1,570 Mil) to Dec. 2024 (€1,295 Mil).

Merck KGaA Other Long-Term Liabilities Historical Data

The historical data trend for Merck KGaA's Other Long-Term Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Merck KGaA Other Long-Term Liabilities Chart

Merck KGaA Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Other Long-Term Liabilities

Get a 7-Day Free Trial

1,877.00

1,799.00

1,747.00

1,570.00

1,295.00

Merck KGaA Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Other Long-Term Liabilities	Get a 7-Day Free Trial															1,496.00	1,402.00	1,295.00	1,295.00	1,224.00

Merck KGaA Other Long-Term Liabilities Calculation

Other Long-Term Liabilities are the other liabilities on the balance sheet that do not need to be repaid within the next 12 months, but still need to be repaid over time. For instance, on Wal-Mart's balance sheet, there are items called Long Term obligations under capital leases, deferred income taxes, and redeemable non-controlling interest. These are all Other Long-Term Liabilities.

Merck KGaA Other Long-Term Liabilities Related Terms

Thank you for viewing the detailed overview of Merck KGaA's Other Long-Term Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Merck KGaA Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Merck KGaA (XTER:MRK) » Definitions » Other Long-Term Liabilities

Traded in Other Exchanges

MKKGY:USA MKGAF:USA 1MRK:Italy MRKd:UK 0O14:UK MRKC:Germany MRKC:Germany MRK:Germany MRK:Germany MRK:Germany MRK:Bulgaria MRCK:Austria

Address

Frankfurter Strasse 250, Darmstadt, HE, DEU, 64293

Website

https://www.emdgroup.com

Merck KGaA operates in three main segments: Life Science, Electronics, and Healthcare. The Life Science segment provides laboratory consumables and instruments to researchers in academia and applied fields, including the biopharmaceutical industry. The Electronics segment offers specialty materials to manufacture a variety of products, such as semiconductors and flat-screen televisions. In the healthcare segment, Merck develops, manufactures, and sells branded pharmaceuticals with significant therapeutic concentrations in oncology, multiple sclerosis, and fertility. In 1995, the E. Merck KG family publicly sold part of the company, resulting in the current 30% public ownership of the firm.

Executives

Peter Guenter	Member of the Executive Board
Dr. Matthias Heinzel	Member of the Executive Board
Belén Garijo Lopez	Chair of the Executive Board
Dr. Marcus Kuhnert	Board of Directors